3D Bioprinting: Commercialising Personalised ATMP/Device Combination Products

This study aims to identify the possible modes of operating a commercial-scale distributed business for bioprinting implants containing living cells. In doing so, it will determine the extent to which the existing non-routine arrangements could be used for commercialisation of personalised Advanced Therapy Medicinal Products (ATMPs) (scaffold/cell combinations) and to identify needs in relation to development of a more appropriate framework for regulation of customised products.

Read more